Education
About Us
Working with TipRanks
Follow Us
DBEU - ETF AI Analysis
Top Page
Xtrackers MSCI Europe Hedged Equity ETF (DBEU)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, including ASML, Nestlé, and Siemens, have shown strong year-to-date performance, supporting the ETF’s overall returns.
Geographic Diversification
The ETF invests across multiple European countries, reducing reliance on any single economy.
Reasonable Expense Ratio
With an expense ratio of 0.45%, the fund offers relatively low costs compared to many actively managed alternatives.
Negative Factors
Underperforming Holding
SAP SE, one of the top holdings, has lagged in year-to-date performance, potentially dragging on the fund’s momentum.
Sector Concentration
The ETF has high exposure to Financials and Industrials, which may increase vulnerability to sector-specific downturns.
Limited U.S. Exposure
With only 5% allocated to U.S. companies, the fund may miss out on growth opportunities in the world’s largest economy.
DBEU vs. SPDR S&P 500 ETF (SPY)
AUM661.02M
RegionEurope
Expense Ratio0.45%
Beta0.60
IssuerXtrackers
Inception DateOct 01, 2013
Dividend Yield2.96%
Asset ClassEquity
Index TrackedMSCI Europe 100% Hedged to USD Net Variant
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume174,290
30 Day Avg. Volume85,317
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
53.15Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering396
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DBEU Summary
The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) is an investment fund that focuses on European companies while protecting against currency fluctuations between the euro and the U.S. dollar. It includes a mix of large and mid-sized companies from 15 developed European countries, such as Nestlé and AstraZeneca, and covers various industries like finance, healthcare, and technology. This ETF is a good choice for investors seeking international diversification with reduced currency risk. However, since it tracks the European market, its performance depends on the economic health of Europe, which can be affected by regional challenges.
How much will it cost me?The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations.
What would affect this ETF?The DBEU ETF could benefit from positive economic growth in Europe, particularly in sectors like financials and industrials, which make up a significant portion of its holdings. Additionally, its currency hedging strategy provides protection against euro-to-dollar fluctuations, which can stabilize returns for U.S. investors. However, potential risks include economic slowdowns in Europe, regulatory changes affecting key industries, or geopolitical tensions that could impact the performance of its top holdings like ASML and Nestlé.
DBEU Top 10 Holdings
The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) leans heavily on European giants like Roche and AstraZeneca, whose steady gains in healthcare have been a bright spot for the fund. HSBC has also been rising, buoyed by strong financial performance and strategic initiatives. However, SAP and Siemens have been lagging, with bearish momentum and mixed signals weighing on industrials and technology exposure. With a notable concentration in financials and industrials, this ETF captures the pulse of developed Europe, offering a balanced mix of steady performers and a few names losing steam.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.18% | $21.27M | €363.99B | 40.40% | 76 Outperform | |
| Roche Holding AG | 2.09% | $13.99M | CHF252.18B | 40.59% | 73 Outperform | |
| AstraZeneca | 2.08% | $13.89M | £210.71B | 28.24% | 80 Outperform | |
| SAP SE | 1.91% | $12.77M | €245.09B | -11.86% | 66 Neutral | |
| HSBC Holdings | 1.88% | $12.58M | HK$1.91T | 45.81% | 80 Outperform | |
| Novartis AG | 1.86% | $12.41M | CHF203.30B | 19.88% | 80 Outperform | |
| Nestlé SA | 1.86% | $12.41M | CHF197.01B | 15.28% | 71 Outperform | |
| Shell (UK) | 1.56% | $10.42M | £156.30B | 8.69% | 73 Outperform | |
| Siemens | 1.53% | $10.21M | €183.31B | 18.27% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.34% | $8.97M | €306.36B | -3.32% | 78 Outperform |
DBEU Technical Analysis
Positive
―
Price Trends
47.23
Positive
46.24
Positive
44.81
Positive
Market Momentum
0.24
Negative
59.27
Neutral
74.25
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 47.45, equal to the 50-day MA of 47.23, and equal to the 200-day MA of 44.81, indicating a bullish trend. The MACD of 0.24 indicates Negative momentum. The RSI at 59.27 is Neutral, neither overbought nor oversold. The STOCH value of 74.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DBEU.
DBEU Peer Comparison
Comparison Results
Performance Comparison
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
48.09
7.47
18.39%
VGK
Vanguard FTSE Europe ETF
―
―
―
EZU
iShares MSCI Eurozone ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents